Clinical Trial

Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in Patients With mCRC

Name: Observational Study Regarding the Combination of Fluoropyrimidine and Bevacizumab in Patients With mCRC — clinical trial record (NCT07494578)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FLOWER

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This study will enroll patients with metastatic colorectal cancer treated with the combination of Trifluridine/Tipiracile and Bevacizumab across 15 italian centers.

Trial Details

NCT Number	NCT07494578
Lead Sponsor	Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions	Colon Cancer Metastatic
Enrollment	300 participants
Start Date	2025-07-01
Primary Completion	2027-07-01 (estimated)
Study Completion	2027-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-27